Skip To Main Content
View Full Results
  • Resource
  • BR1DGE
  • Monitoring
  • Staging
  • Infographic

Monitoring Individuals with IAb Positive Status

Explore how clinical outcomes are impacted by screening and monitoring

Learning Objectives

  • Understand the benefits of early identification and monitoring of individuals with positive islet autoantibody status

Summary

Individuals with positive islet autoantibody (IAb) status can be identified early via IAb screening. Individuals who test positive for IAbs include those who are at risk of developing presymptomatic T1D (Stages 1 and 2) (1 IAb) or have presymptomatic T1D (Stage 1 or 2) (≥2 IAbs).

Early identification and subsequent monitoring of individuals with positive IAb status can provide time to prepare for the future. Screening and monitoring can lead to beneficial clinical outcomes at onset of Stage 3 T1D and beyond.

Download

Islet autoantibodies Screening

MAT-GLB-2405124-1.0 - 12/2024

Similar Content
Autoimmune T1D Imposes a Psychosocial Burden on Affected Children and Their Carers
  • Disease Burden
  • Monitoring
  • Staging
  • Video

Autoimmune T1D Imposes a Psychosocial Burden on Affected Children and Their Carers

Early identification of presymptomatic autoimmune T1D may reduce the psychological burden experienced at diagnosis by giving time for preparation and education

Discover more
Implications for Children Diagnosed at Clinical Onset of T1D Without Early Identification
  • Disease Burden
  • Staging
  • Video

Potential Implications for Children Diagnosed at Clinical Onset of T1D Stage 3

Rosa is an 8-year-old child with presymptomatic autoimmune T1D, but neither she nor her family know this yet. Without prior knowledge, she may be at increased risk of DKA at clinical onset of T1D

Discover more
The Role of GWAS and GRS in T1D
  • Staging
  • Video

The role of GWAS and GRS in T1D

Explore the association of GWAS and GRS and how they can improve T1D

Discover more